文献速递前列腺增生与排尿功能障碍

MOSES™技术与传统钬激光前列腺剜除术对比:来自高容量中心的随机对照试验

MOSES™ Technology vs Non-Moses Holmium Laser Enucleation of the Prostate: A Randomized Controlled Trial From a High-Volume Center.
PubMed 文献 · Urology · 2024-03-13

在中国上海开展的单盲、前瞻性、平行随机对照试验,比较MOSES™增强钬激光前列腺剜除术(MoLEP)与非MOSES钬激光前列腺剜除术(HoLEP)的剜除效率、止血效果及日间手术适用性。共100例符合BPH手术指征的50岁以上男性随机分组,最终分析80例(MoLEP 38例、HoLEP 42例)。MoLEP在术后护理需求、导尿管留置时间和住院时间方面显示出潜在优势。

要点

  • MoLEP剜除效率为3.5±0.8 g/min、剜除时间22.5±7.6分钟,优于HoLEP但未达统计学显著。
  • MoLEP止血时间6.6±4.2分钟,短于HoLEP的11.2±5.1分钟。
  • MoLEP导尿管留置时间1.3±0.1天,术后膀胱冲洗需求更少,住院时间更短。

核心结论

  • 部分结局指标未达统计学显著,但MoLEP在术后护理需求、更短导尿管留置时间和更短住院时间方面显示出潜在优势,提示其在日间手术场景中的可行性和安全性。
  • 两组术后功能结局均显著改善。

研究设计与样本

  • 单盲、前瞻性、平行随机对照试验,于2022年3月至12月在中国上海开展。
  • 已获伦理批准(SK2020-038),100例同意参与的、50岁以上且符合BPH手术指征的男性按1:1随机分为MoLEP组和HoLEP组。
  • 手术流程标准化,结局由盲法分析人员评估。
  • 最终分析80例参与者数据(MoLEP组38例,HoLEP组42例),基线特征可比。

主要发现

  • MoLEP剜除效率为3.5±0.8 g/min,剜除时间为22.5±7.6分钟,优于HoLEP但未达统计学显著。
  • MoLEP止血时间为6.6±4.2分钟,HoLEP为11.2±5.1分钟。
  • MoLEP术后膀胱冲洗需求少于HoLEP。
  • MoLEP平均导尿管留置时间为1.3±0.1天,住院时间较HoLEP缩短。
  • 两组术后功能结局均显著改善。

临床怎么用

  • 作者认为,MoLEP在术后护理需求、导尿管留置时间和住院时间方面的潜在优势提示其用于日间手术场景的可行性和安全性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Benign prostatic hyperplasia (BPH) management has evolved from transurethral resection of the prostate (TURP) to holmium laser enucleation of the prostate (HoLEP). Recent innovation introduces Moses™ technology in holmium lasers, with the Lumenis Pulse™ system. METHODS: To compare Moses-augmented HoLEP (MoLEP) to non-Moses HoLEP in terms of enucleation efficiency, hemostasis, and applicability in day surgery settings. A single-blind, prospective, parallel randomized controlled trial was conducted in Shanghai, China, from March to December 2022. Ethical approval (SK2020-038) was obtained, and 100 consenting men over 50 with BPH indications were randomized (1:1) into MoLEP and HoLEP groups. Surgical procedures were standardized, and outcomes were assessed by blinded analysts. RESULTS: Data from 80 participants (38 MoLEP, 42 HoLEP) were analyzed. Baseline characteristics were comparable. MoLEP demonstrated superior enucleation efficiency (3.5±0.8 g/min) and shorter enucleation time (22.5±7.6 minutes) compared to HoLEP, although not statistically significant. MoLEP achieved hemostasis in less time (6.6±4.2 minutes) than HoLEP (11.2±5.1 minutes). Postoperative care demands varied, with MoLEP requiring less bladder irrigation. MoLEP exhibited a shorter average catheterization time (1.3±0.1 days) and reduced hospitalization compared to HoLEP. Both groups showed significant postoperative improvements in functional outcomes. CONCLUSION: While statistical significance was not achieved in certain outcome measures, MoLEP exhibited potential advantages in postoperative care demands, shorter catheterization time, and reduced hospitalization, suggesting its feasibility and safety in day surgery settings. Postoperative functional outcomes improved significantly in both groups.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Tong Z, Sherryn S, Xia S, et al. MOSES™ Technology vs Non-Moses Holmium Laser Enucleation of the Prostate: A Randomized Controlled Trial From a High-Volume Center. Urology. 2024. PMID: 38490277. doi:10.1016/j.urology.2024.03.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。